| __timestamp | Arrowhead Pharmaceuticals, Inc. | MannKind Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 79383000 |
| Thursday, January 1, 2015 | 34718089 | 108402000 |
| Friday, January 1, 2016 | 40998209 | 46928000 |
| Sunday, January 1, 2017 | 32022880 | 74959000 |
| Monday, January 1, 2018 | 19110051 | 79716000 |
| Tuesday, January 1, 2019 | 26556257 | 74669000 |
| Wednesday, January 1, 2020 | 52275890 | 59040000 |
| Friday, January 1, 2021 | 80981000 | 77417000 |
| Saturday, January 1, 2022 | 124431000 | 91473000 |
| Sunday, January 1, 2023 | 90932000 | 94314000 |
| Monday, January 1, 2024 | 98761000 |
Infusing magic into the data realm
In the competitive world of biotechnology, operational efficiency is key. Arrowhead Pharmaceuticals, Inc. and MannKind Corporation, two prominent players, have shown contrasting trends in their Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. Arrowhead Pharmaceuticals has seen a significant increase, with expenses growing by over 300% from 2014 to 2022, peaking in 2022. This suggests a strategic expansion or increased operational activities. In contrast, MannKind Corporation's SG&A expenses have remained relatively stable, with a slight increase of about 20% over the same period. Notably, 2023 data for MannKind is missing, leaving room for speculation on their current financial strategy. These trends highlight the differing approaches of these companies in managing operational costs, reflecting their unique business strategies and market positions.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MannKind Corporation
Comparing SG&A Expenses: Genmab A/S vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Viatris Inc. and MannKind Corporation
Operational Costs Compared: SG&A Analysis of Halozyme Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or MannKind Corporation
Comparing SG&A Expenses: Alkermes plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and Mesoblast Limited
Arrowhead Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Arrowhead Pharmaceuticals, Inc. and Evotec SE
Breaking Down SG&A Expenses: MannKind Corporation vs Travere Therapeutics, Inc.
MannKind Corporation and Novavax, Inc.: SG&A Spending Patterns Compared